Molnupiravir (EIDD-2801) - Moligand™, ≥99% , CAS No.2349386-89-4

CAS: 2349386-89-4 Cat. No.: M406650 Summenformel: C₁₃H₁₉N₃O₇ Molekulargewicht: 329.31 EG-Nummer: 859-180-1

GRADE & PURITY Moligand™, ≥99%

Synonyms

EIDD2801 | EIDD-2801 | Molnupiravir [INN] | SARS-CoV-2 antiviral agents: molnupiravir | A936190 | Lagevrio | DTXSID501028058 | ((2R,3S,4R,5R)-3,4-dihydroxy-5-((4Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)oxolan-2-yl)methyl 2-methylpropanoate

Storage

Store at -20°C

Shipped In

Ice chest + Ice pads

Specifications

Synonyme

EIDD2801 | EIDD-2801 | Molnupiravir [INN] | SARS-CoV-2 antiviral agents: molnupiravir | A936190 | Lagevrio | DTXSID501028058 | ((2R,3S,4R,5R)-3,4-dihydroxy-5-((4Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)oxolan-2-yl)methyl 2-methylpropanoate

Spezifikationen & Reinheit

Moligand™, ≥99%

Biochemische und physiologische Mechanismen

EIDD-2801 is 5′-isopropylester prodrug form of the antiviral ribonucleoside analog N4-hydroxycytidine (NHC, EIDD-1931) with known anti-viral activity against SARS-CoV, SARS-CoV-2, RSV, influenza A & B (IAV & IBV), HCV, pestivirus, bovine viral diarrhoea v

Storage

Store at -20°C

Verschickt in

Ice chest + Ice pads

Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.

Note

Moligand™

Reinheit

≥99%

Produkteigenschaften

• hba_count: 7
• HBD-Zahl: 4
• Rotationsfähige Bindung: 6

Namen und Kennungen

• Pubchem Sid: 504773602
• Pubchem Sid Url: https://pubchem.ncbi.nlm.nih.gov/substance/504773602
• Kanonisches Lächeln: CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)NO)O)O
• IUPAC Name: [(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate
• InChIKey: HTNPEHXGEKVIHG-QCNRFFRDSA-N
• INCHI: 1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/m1/s1
• Isomere SMILES: CC(C)C(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=NC2=O)NO)O)O
• Molekulargewicht: 329.31
• Reaxy-Rn: 38838818
• Reaxys-RN_link_address: https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=38838818&ln=

Taxonomic Classification

Taxonomy Tree

• Kingdom Organic compounds
  • Superclass Nucleosides, nucleotides, and analogues
    • Klasse Pyrimidine nucleosides

• Kingdom: Organic compounds
• Superclass: Nucleosides, nucleotides, and analogues
• Klasse: Pyrimidine nucleosides
• Subclass: Not available
• Intermediate Tree Nodes: Not available
• Direct Parent: Pyrimidine nucleosides
• Alternative Parents: Glycosylamines Arylhydroxamates Pyrimidones Monosaccharides Imidolactams Hydropyrimidines Tetrahydrofurans Heteroaromatic compounds Secondary alcohols Carboxylic acid esters 1,2-diols Oxacyclic compounds N-organohydroxylamines Monocarboxylic acids and derivatives Azacyclic compounds Organopnictogen compounds Organic oxides Hydrocarbon derivatives Carbonyl compounds
• Molecular Framework: Aromatic heteromonocyclic compounds
• Substituents: Pyrimidine nucleoside - N-glycosyl compound - Glycosyl compound - Arylhydroxamate - Pyrimidone - Imidolactam - Pyrimidine - Monosaccharide - Hydropyrimidine - Heteroaromatic compound - Tetrahydrofuran - Secondary alcohol - Carboxylic acid ester - 1,2-diol - Oxacycle - Azacycle - N-organohydroxylamine - Organoheterocyclic compound - Monocarboxylic acid or derivatives - Carboxylic acid derivative - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Carbonyl group - Alcohol - Aromatic heteromonocyclic compound
• Beschreibung: This compound belongs to the class of organic compounds known as pyrimidine nucleosides. These are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety.
• External Descriptors: Not available

Data sources

1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.

DOI: 10.1186/s13321-016-0174-y

Zugehörige Ziele (nicht menschlich)

Influenza B virus (2113 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Influenza A virus (11224 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

BHK-21 (725 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

MDCK (10148 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Vero (26788 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

dengue virus type 2 (2400 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Wirkungsmechanismen

Chemische und physikalische Eigenschaften

• Löslichkeit: In DMSO, the highest concentration (mg/mL) : 66, the highest concentration (mM) : 200.42; in Ethanol, the highest concentration (MG/ML) : 22, the highest concentration (mM) : 66.81; in water, the highest concentration (mg/mL) : 20, the highest concentrati
• Molekulargewicht: 329.310 g/mol
• XLogP3: -0.800
• Hydrogen Bond Donor Count: 4
• Hydrogen Bond Acceptor Count: 7
• Rotatable Bond Count: 6
• Exact Mass: 329.122 Da
• Monoisotopic Mass: 329.122 Da
• Topological Polar Surface Area: 141.000 Ų
• Heavy Atom Count: 23
• Formal Charge: 0
• Complexity: 534.000
• Isotope Atom Count: 0
• Defined Atom Stereocenter Count: 4
• Undefined Atom Stereocenter Count: 0
• Defined Bond Stereocenter Count: 0
• Undefined Bond Stereocenter Count: 0
• The total count of all stereochemical bonds: 0
• Covalently-Bonded Unit Count: 1

Referenzen

1. Kangning Sun, Peizhuo Han, Changlin Yao, Yaning Zhao, Chuanchi Zhang, Yao Zhang, Jingke Jiang, Lei Wang.  (2024)  Surface Accelerates Crystal Nucleation: The Case of Molnupiravir.  CRYSTAL GROWTH & DESIGN,      [PMID:] [10.1021/acs.cgd.4c00650]

2. Peizhuo Han, Lei Wang, Shuhong Song, Changlin Yao, Xutang Tao, Guanying Xie, Huimin Li, Yaqian Qu, Hongshuai Wang, Zeliang Gao, Yanyan Sun, Huachang Wu, Weiguo Song.  (2024)  Polymorphs and Solvates of Molnupiravir: Crystal Structures and Solid Forms Transformation Analysis.  CRYSTAL GROWTH & DESIGN,      [PMID:] [10.1021/acs.cgd.4c00376]

3. Peizhuo Han, Lei Wang, Huimin Li, Changlin Yao, Yaqian Qu, Xu Zhang, Hanlin Zhao, Yaqi Ren, Bozhang Li, Lufeng Xu, Weiguo Song, Xutang Tao.  (2025)  The new cocrystal of molnupiravir-caprolactam discovered by melt crystallization with improved tableting properties.  INTERNATIONAL JOURNAL OF PHARMACEUTICS,      [PMID:40318832] [10.1016/j.ijpharm.2025.125661]